Skip to main content
. Author manuscript; available in PMC: 2011 Nov 10.
Published in final edited form as: Virology. 2010 Sep 6;407(1):160–170. doi: 10.1016/j.virol.2010.08.009

Fig. 6.

Fig. 6

Dynasore inhibits both HCVpp and HCVcc entry. (A) Schematic drawing of the experimental setup. Huh7.5.1 cells were treated with Dynasore or DMSO under four different protocols, differing in duration of the treatment and the time when added. A series of concentrations were tested and the selected Dynasore concentration (80 μM) was tested not to exert noticeable effect on cell growth. (B) Treated Huh7.5.1 cells were analyzed for relative susceptibility to HCVpp, HCVcc-luc, and VSV-Gpp. All results are expressed as percent infection to the DMSO treated cells. Data are presented as mean ± standard deviation. *** p<0.0005, ** p<0.005, * p<0.05.